Publication | Closed Access

Randomized, Double-Blind Study Comparing Saruplase With Streptokinase Therapy in Acute Myocardial Infarction: The COMPASS Equivalence Trial fn1fn1This study was supported by Grünenthal GmbH, the manufacturer of saruplase.

ThrombosisCardiovascular DiseaseMedicineClinical TrialsCardiovascular PharmacologyGrünenthal GmbhStreptokinase TherapyPharmacotherapyPharmacologyCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction